4//SEC Filing
Duarte Ira 4
Accession 0001193125-25-264039
CIK 0000818033other
Filed
Nov 3, 7:00 PM ET
Accepted
Nov 4, 12:33 PM ET
Size
6.9 KB
Accession
0001193125-25-264039
Insider Transaction Report
Form 4
Duarte Ira
EVP, Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-10-31+11,694→ 179,786 total - Exercise/Conversion
Restricted Stock Units
2025-10-31−11,694→ 152,027 totalExercise: $0.00→ Common Stock (11,694 underlying)
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]The restricted stock units vest in 16 equal installments beginning one quarter after the date of grant (January 31, 2025).
Documents
Issuer
HERON THERAPEUTICS, INC. /DE/
CIK 0000818033
Entity typeother
Related Parties
1- filerCIK 0001488864
Filing Metadata
- Form type
- 4
- Filed
- Nov 3, 7:00 PM ET
- Accepted
- Nov 4, 12:33 PM ET
- Size
- 6.9 KB